Literature DB >> 22245283

Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis.

Anna Boronat1, María Sepúlveda, Sara Llufriu, Lidia Sabater, Yolanda Blanco, Iñigo Gabilondo, Nuria Solà, Pablo Villoslada, Josep Dalmau, Francesc Graus, Albert Saiz.   

Abstract

Contactin-2 was recently identified as an autoantigen targeted by T-cells and autoantibodies in multiple sclerosis (MS). Here we analyzed the frequency of antibodies to contactin-2 (contactin-2-ab) by a cell-based assay in the serum from 105 MS patients and at least 5 years of follow-up (19 clinically isolated syndromes, 51 relapsing-remitting, 20 secondary-progressive, and 15 primary-progressive). Contactin-2-ab were detected in 4 (7.8%) relapsing-remitting patients. Clinical and magnetic resonance imaging characteristics were not significantly different from the rest of relapsing-remitting patients. In conclusion, contactin-2-ab are identified in a minority of MS patients but their presence is not associated with a particular clinical-radiological profile. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245283      PMCID: PMC4800093          DOI: 10.1016/j.jneuroim.2011.12.023

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  21 in total

1.  T2 hypointense rims and ring-enhancing lesions in MS.

Authors:  Sara Llufriu; Teresa Pujol; Yolanda Blanco; Karolina Hankiewicz; Mattia Squarcia; Joan Berenguer; Pablo Villoslada; Francesc Graus; Albert Saiz
Journal:  Mult Scler       Date:  2010-08-04       Impact factor: 6.312

Review 2.  Antibodies as biological markers for pathophysiological processes in MS.

Authors:  Markus Reindl; Michael Khalil; Thomas Berger
Journal:  J Neuroimmunol       Date:  2006-08-23       Impact factor: 3.478

3.  GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

Authors:  A Boronat; L Sabater; A Saiz; J Dalmau; F Graus
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

Review 4.  The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.

Authors:  Michael K Racke
Journal:  Curr Opin Neurol       Date:  2008-04       Impact factor: 5.710

5.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

6.  Homogeneity of active demyelinating lesions in established multiple sclerosis.

Authors:  Esther C W Breij; Bianca P Brink; Rob Veerhuis; Christa van den Berg; Rianka Vloet; Riqiang Yan; Christine D Dijkstra; Paul van der Valk; Lars Bö
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

Review 7.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

8.  Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.

Authors:  Tobias Derfuss; Khyati Parikh; Sviataslau Velhin; Magdalena Braun; Emily Mathey; Markus Krumbholz; Tania Kümpfel; Anja Moldenhauer; Christoph Rader; Peter Sonderegger; Walter Pöllmann; Christian Tiefenthaller; Jan Bauer; Hans Lassmann; Hartmut Wekerle; Domna Karagogeos; Reinhard Hohlfeld; Christopher Linington; Edgar Meinl
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

9.  Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1.

Authors:  Sebastian Poliak; Daniela Salomon; Hadas Elhanany; Helena Sabanay; Brent Kiernan; Larysa Pevny; Colin L Stewart; Xiaorong Xu; Shing-Yan Chiu; Peter Shrager; Andrew J W Furley; Elior Peles
Journal:  J Cell Biol       Date:  2003-09-08       Impact factor: 10.539

10.  Neurofascin as a novel target for autoantibody-mediated axonal injury.

Authors:  Emily K Mathey; Tobias Derfuss; Maria K Storch; Kieran R Williams; Kimberly Hales; David R Woolley; Abdulmonem Al-Hayani; Stephen N Davies; Matthew N Rasband; Tomas Olsson; Anja Moldenhauer; Sviataslau Velhin; Reinhard Hohlfeld; Edgar Meinl; Christopher Linington
Journal:  J Exp Med       Date:  2007-09-10       Impact factor: 14.307

View more
  6 in total

Review 1.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 2.  Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.

Authors:  Panos Stathopoulos; Harry Alexopoulos; Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

Review 3.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

Review 4.  Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder.

Authors:  Madeline Eve; Josan Gandawijaya; Liming Yang; Asami Oguro-Ando
Journal:  Front Psychiatry       Date:  2022-04-15       Impact factor: 5.435

Review 5.  Implication of Contactins in Demyelinating Pathologies.

Authors:  Ilias Kalafatakis; Maria Savvaki; Theodora Velona; Domna Karagogeos
Journal:  Life (Basel)       Date:  2021-01-13

Review 6.  B cell depletion therapies in autoimmune disease: advances and mechanistic insights.

Authors:  Dennis S W Lee; Olga L Rojas; Jennifer L Gommerman
Journal:  Nat Rev Drug Discov       Date:  2020-12-15       Impact factor: 84.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.